Hunan Hansen Pharmaceutical Co Ltd Net Asset Quality Index

Latest as of March 2026: 88.6%

Hunan Hansen Pharmaceutical Co Ltd net asset quality index. Hunan Hansen Pharmaceutical Co Ltd (002412) has a Net Asset Quality Index of 88.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.73 Billion minus total liabilities of CN¥310.49 Million yields net assets of CN¥2.42 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 002412 book value for net asset value and shareholders' equity analysis.

Quality Index

88.6%
Equity / Total Assets

Net Assets

CN¥2.42 Billion
CNY

Total Assets

CN¥2.73 Billion
CNY

Total Liabilities

CN¥310.49 Million
CNY

Net Asset Quality Index of Hunan Hansen Pharmaceutical Co Ltd (2006–2025)

Net asset quality index of Hunan Hansen Pharmaceutical Co Ltd from 2006 to 2025. This chart shows how Hunan Hansen Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the index stands at 88.6%, representing net assets of CN¥2.42 Billion against total assets of CN¥2.73 Billion CNY. Check Hunan Hansen Pharmaceutical Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Hunan Hansen Pharmaceutical Co Ltd Net Asset Quality Index by Year (2006–2025)

Hunan Hansen Pharmaceutical Co Ltd net asset quality index by year from 2006 to 2025. The table below presents the year-by-year Net Asset Quality Index for Hunan Hansen Pharmaceutical Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Hunan Hansen Pharmaceutical Co Ltd market cap and net worth.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 88.4% CN¥2.38 Billion CN¥2.69 Billion CN¥312.15 Million ▲ +1.9 pp
2024 86.5% CN¥2.20 Billion CN¥2.55 Billion CN¥343.85 Million ▲ +2.5 pp
2023 84.0% CN¥1.96 Billion CN¥2.34 Billion CN¥373.46 Million ▲ +1.3 pp
2022 82.7% CN¥1.89 Billion CN¥2.29 Billion CN¥396.81 Million ▲ +0.2 pp
2021 82.5% CN¥1.74 Billion CN¥2.11 Billion CN¥368.99 Million ▼ -1.9 pp
2020 84.4% CN¥1.59 Billion CN¥1.89 Billion CN¥293.92 Million ▲ +3.2 pp
2019 81.3% CN¥1.53 Billion CN¥1.88 Billion CN¥352.93 Million ▲ +5.4 pp
2018 75.8% CN¥1.36 Billion CN¥1.80 Billion CN¥435.02 Million ▲ +4.1 pp
2017 71.7% CN¥1.22 Billion CN¥1.70 Billion CN¥481.18 Million ▼ -3.5 pp
2016 75.2% CN¥1.26 Billion CN¥1.67 Billion CN¥415.88 Million ▼ -15.6 pp
2015 90.8% CN¥1.25 Billion CN¥1.38 Billion CN¥126.83 Million ▲ +6.5 pp
2014 84.3% CN¥1.15 Billion CN¥1.37 Billion CN¥214.59 Million ▲ +0.5 pp
2013 83.8% CN¥1.11 Billion CN¥1.32 Billion CN¥214.46 Million ▼ -8.9 pp
2012 92.6% CN¥965.11 Million CN¥1.04 Billion CN¥76.76 Million ▼ -1.5 pp
2011 94.1% CN¥883.65 Million CN¥938.60 Million CN¥54.95 Million ▼ -0.7 pp
2010 94.8% CN¥898.82 Million CN¥948.05 Million CN¥49.23 Million ▲ +22.2 pp
2009 72.6% CN¥179.51 Million CN¥247.20 Million CN¥67.69 Million ▲ +12.0 pp
2008 60.6% CN¥130.26 Million CN¥214.93 Million CN¥84.67 Million ▲ +10.2 pp
2007 50.4% CN¥87.77 Million CN¥174.25 Million CN¥86.49 Million ▲ +18.6 pp
2006 31.8% CN¥67.28 Million CN¥211.73 Million CN¥144.46 Million —
pp = percentage points